ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 952,53
0,76%
Dow Jones
44 565,07
0,00%
DAX
21 449,64
0,15%
Brent Oil
78,115
1,02%
Bitcoin
105 268,04
1,25%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. PTC Therapeutics Inc (PTCT) Cours

PTC Therapeutics Inc

PTC Therapeutics Inc (PTCT)

NASDAQ
45,08
0,00
(0,00%)
Fermé 24 Janvier 10:00PM
Retardé de 15 minutes
47,30
1,12
( 2,43% )
Avant marché: 1:54PM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
47,30
Prix Achat
44,86
Prix Vente
48,00
Volume échangé
512
0,00 Fourchette du Jour 0,00
23,58 Plage de 52 semaines 54,16
Cap du marché
3,648B
Clôture Veille
46,18
Ouverture
-
Dernière Transaction
1
@
46
Dernière heure de transaction
13:54:37
Volume financier
-
VWAP
-
Volume moyen (3 m)
722 092
Actions en circulation
77 125 143
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-5,68
Bénéfice par action (BPA)
-8,12
Chiffre d'affairess
1,07B
Bénéfice net
-626,6M

À propos de PTC Therapeutics Inc

PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is... PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.ptcbio.com
Siège social
Wilmington, Delaware, USA
Fondé
-
PTC Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker PTCT. Le dernier cours de clôture d'PTC Therapeutics était de US$46,18. Au cours de la dernière année, les actions de PTC Therapeutics ont été négociées dans une fourchette de prix de US$ 23,58 à US$ 54,16.

PTC Therapeutics compte actuellement 77 125 143 actions en circulation. La capitalisation boursière d'PTC Therapeutics est de US$3,56 milliard. PTC Therapeutics a un ratio cours/bénéfice (ratio PE) de -5.68.

PTCT Dernières nouvelles

Plus de nouvelles

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire WARREN, N.J., Jan. 13, 2025 WARREN, N.J., Jan. 13, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ:...

13 Janvier 2025
PR Newswire (US)

Form 8-K - Current report

13 Janvier 2025
Edgar (US Regulatory)

PTC Therapeutics Provides Update on Commercial Performance and R&D Pipeline at 43rd Annual J.P. Morgan Healthcare Conference

PTC Therapeutics Provides Update on Commercial Performance and R&D Pipeline at 43rd Annual J.P. Morgan Healthcare Conference PR Newswire WARREN, N.J., Jan. 13, 2025 – Unaudited 2024 total...

13 Janvier 2025
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

10 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

10 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

10 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

10 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

10 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

10 Janvier 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

10 Janvier 2025
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
13.999.2126529669843.3147.542.1877410544.62965139CS
42.1154.6807568883545.18547.541.66558094944.40859683CS
127.3318.338754065539.9754.1638.2672209245.54568984CS
2613.8841.532016756433.4254.1629.01568434640.41253629CS
5218.9466.78420310328.3654.1623.5879656334.98800716CS
1569.0923.789583878638.2159.8417.5381808836.30162543CS
260-6.26-11.687826736453.5670.8217.5373291540.27049206CS

PTCT - Frequently Asked Questions (FAQ)

What is the current PTC Therapeutics share price?
The current share price of PTC Therapeutics is US$ 47,30
How many PTC Therapeutics shares are in issue?
PTC Therapeutics has 77 125 143 shares in issue
What is the market cap of PTC Therapeutics?
The market capitalisation of PTC Therapeutics is USD 3,56B
What is the 1 year trading range for PTC Therapeutics share price?
PTC Therapeutics has traded in the range of US$ 23,58 to US$ 54,16 during the past year
What is the PE ratio of PTC Therapeutics?
The price to earnings ratio of PTC Therapeutics is -5,68
What is the cash to sales ratio of PTC Therapeutics?
The cash to sales ratio of PTC Therapeutics is 3,34
What is the reporting currency for PTC Therapeutics?
PTC Therapeutics reports financial results in USD
What is the latest annual turnover for PTC Therapeutics?
The latest annual turnover of PTC Therapeutics is USD 1,07B
What is the latest annual profit for PTC Therapeutics?
The latest annual profit of PTC Therapeutics is USD -626,6M
What is the registered address of PTC Therapeutics?
The registered address for PTC Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the PTC Therapeutics website address?
The website address for PTC Therapeutics is www.ptcbio.com
Which industry sector does PTC Therapeutics operate in?
PTC Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
EVAXEvaxion Biotech AS
US$ 8,24
(126,37%)
13,62M
STBXStarBox Group Holdings Ltd
US$ 0,9042
(77,26%)
12,69M
IROHIron Horse Acquisition Corporation
US$ 16,45
(58,94%)
6
CRWSCrown Crafts Inc
US$ 6,99
(55,68%)
1
IZTCInvizyne Technologies Inc
US$ 18,00
(51,39%)
6
TOIIWOncology Institute Inc
US$ 0,0126
(-44,00%)
365
MDXGMiMedx Group Inc
US$ 5,11
(-43,41%)
128
IROQIF Bancorp Inc
US$ 14,01
(-41,89%)
3
LRFCLogan Ridge Finance Corporation
US$ 14,01
(-41,65%)
17
LITMSnow Lake Resources Ltd
US$ 0,931
(-33,02%)
4,04M
ACONAclarion Inc
US$ 0,056
(29,63%)
77,35M
BTAIBioXcel Therapeutics Inc
US$ 0,3856
(1,53%)
16,66M
ATXIAvenue Therapeutics Inc
US$ 1,97
(7,07%)
15,21M
EVAXEvaxion Biotech AS
US$ 8,46
(132,42%)
13,63M
STBXStarBox Group Holdings Ltd
US$ 0,9086
(78,12%)
12,69M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
PTCT
PTC Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés